| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Immunology, United States Army Institute of Dental Research, Walter Reed Army Medical Center, Washington, D.C. 20012, the Laboratory of Microbiology and Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pharmacology, University of Rochester, School of Medicine, Rochester, New York 14642
Abstract
Supernatants from cultures of activated normal human peripheral blood leukocytes contain a factor which stimulates osteoclastic bone resorption in vitro. The present study indicates that osteoclast activating factor (OAF) is produced by phytohemagglutinin-activated mononuclear cells within 6 hr of activation, and that peak production is associated with increased amino acid incorporation into protein but precedes increased thymidine incorporation into DNA. Granulocytes, platelets, and red cells were not necessary for the production of OAF, since mononuclear cells purified on Ficoll-Hypaque gradients and devoid of these elements produced as much OAF as unseparated leukocytes. Granulocyte extracts did not show bone-resorbing activity. The production of OAF by mononuclear cells was impaired by irradiation, suggesting that it is made by radiosensitive lymphocytes rather than radioresistant macrophages. However, OAF was not produced by lymphocytes purified on glass-bead columns although these cells could respond to phytohemagglutinin with increased thymidine and amino acid incorporation. Purified macrophages also failed to produce substantial bone-resorbing activity. However, when a small number of irradiated but viable macrophages (5 x 104 cells/ml) was added to glass bead-purified lymphocytes (2 x 106 cells/ml), OAF production was as great as with unseparated mononuclear cell populations. These results suggest that OAF is produced by lymphocytes, but that its production is dependent on macrophage-lymphocyte interaction. OAF is a unique bone-resorbing factor which may play an important role in bone lesions associated with chronic inflammation and neoplasia. The cellular mechanisms for its production participate in the pathogenesis of these disorders.
Footnotes
1 This study was supported in part by Grants AM-06205 and DE-03725 from the United States Public Health Service.
2 Department of Immunology, United States Army Institute of Dental Research, Walter Reed Army Medical Center, Washington, D.C. 20012.
3 Laboratory of Microbiology and Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20014.
4 Department of Pharmacology, University of Rochester, School of Medicine, Rochester, New York 14642.
This article has been cited by other articles:
|
|
 |
|
  K. L. Becker, E. S. Nylen, J. C. White, B. Muller, and R. H. Snider Jr. Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its Precursors J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1512 - 1525. [Full Text] [PDF]
|
|
|
|
 |
|
 D O' Gradaigh, D Ireland, S Bord, and J E Compston Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor {alpha}, interleukin 1, and receptor activator of nuclear factor {kappa}B ligand (RANKL) regulate osteoclasts Ann Rheum Dis, April 1, 2004; 63(4): 354 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O'Gradaigh and J. E. Compston T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion Rheumatology, February 1, 2004; 43(2): 122 - 130. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Horton, F. Wezeman, and K. Kuettner Inhibition of bone resorption in vitro by a cartilage-derived anticollagenase factor Science, March 24, 1978; 199(4335): 1342 - 1345. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
